|
SF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64013247427874E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92601490311972E-12 |
| Normal-vs-Stage2 |
2.19849999999466E-05 |
| Normal-vs-Stage3 |
7.54210000009081E-07 |
| Normal-vs-Stage4 |
8.47480000000234E-05 |
| Stage1-vs-Stage2 |
7.235600E-01 |
| Stage1-vs-Stage3 |
5.545000E-01 |
| Stage1-vs-Stage4 |
7.391000E-01 |
| Stage2-vs-Stage3 |
9.014000E-01 |
| Stage2-vs-Stage4 |
6.198600E-01 |
| Stage3-vs-Stage4 |
4.853000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6787682355357E-12 |
| Normal-vs-AfricanAmerican |
5.56330004286565E-09 |
| Normal-vs-Asian |
5.34640000049436E-07 |
| Caucasian-vs-AfricanAmerican |
3.907200E-01 |
| Caucasian-vs-Asian |
5.496800E-01 |
| AfricanAmerican-vs-Asian |
3.505600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27739999689069E-08 |
| Normal-vs-Female |
2.61890000019527E-07 |
| Male-vs-Female |
5.354200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.43019995425232E-09 |
| Normal-vs-Extreme_Weight |
9.46189793182839E-11 |
| Normal-vs-Obese |
1.9488999969397E-08 |
| Normal-vs-Extreme_Obese |
3.76889999997854E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.483400E-01 |
| Normal_Weight-vs-Obese |
6.474200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.247750E-01 |
| Extreme_Weight-vs-Obese |
2.536800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.020000E-01 |
| Obese-vs-Extreme_Obese |
9.789500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.228300E-04 |
| Normal-vs-Age(41-60Yrs) |
4.15229961525654E-10 |
| Normal-vs-Age(61-80Yrs) |
2.91988655476416E-14 |
| Normal-vs-Age(81-100Yrs) |
3.5761000000134E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.077800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.841380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.126500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.803700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.174300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.416400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.22000187730009E-11 |
| Normal-VS-Type2 PRCC |
8.82369954879891E-10 |
| Normal-VS-KIRP CIMP |
3.831500E-04 |
| Normal-VS-Unclassified PRCC |
9.51460000009341E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.422600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.618800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.827400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.623000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.152100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.848200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85089998883115E-09 |
| Normal-vs-N1 |
1.360200E-04 |
| Normal-vs-N2 |
1.216550E-03 |
| N0-vs-N1 |
3.272300E-02 |
| N0-vs-N2 |
2.806400E-01 |
| N1-vs-N2 |
9.637900E-02 |
|
|
